Scientists test drug duos to fight cancer in the brain
NCT ID NCT05704933
Summary
This small, early study tested the safety and feasibility of giving a single dose of one of two different drug combinations to patients with melanoma that had spread to the brain. The patients then had surgery to remove the brain tumor 7-10 days later. The main goal was to see if researchers could recruit enough patients and to study how the drugs changed the immune cells in and around the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M.D. Anderson Cancer Center
Houston, Texas, 77030, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.